Reports

102 Results (Page 1 of 5)

Mexico Markets Research Reports

Pharmaceuticals

Mexico Dermatological Therapeutics Market Analysis

Mexico Dermatological Therapeutics Market is at around $0.62 Bn in 2022 and is projected to reach $1.11 Bn in 2030, exhibiting a CAGR of 8.85% during the forecast period. The market is rapidly expanding as a result of the increased prevalence of dermatological conditions, rising awareness about skin disorders, and technological advancements in the industry. The market is dominated by key players like Genomma Lab Internacional, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma Laboratories, Bausch Health Companies Inc., Novartis AG, Eli Lily and Company, and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Alopecia (Hair Loss) Therapeutics Market Analysis

The Mexico Alopecia (Hair Loss) Therapeutics Market was valued at US $123 Mn in 2022, and is predicted to grow at (CAGR) of 7.75% from 2023 to 2030, to US $223 Mn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, lifestyle changes and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Pfizer, Cipla, Sun Pharmaceuticals, and iRestore, among others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

Mexico Digital Therapeutics Market Analysis

Mexico Digital Therapeutics Market is at around $93 Mn in 2023 and is projected to reach $508 Mn in 2030, exhibiting a CAGR of 27.45% during the forecast period. The market is propelling due to factors such as the rising prevalence of chronic diseases, the expansion of telehealth, and the rise in patient engagement and awareness. The market is dominated by key players like Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Allergy Therapeutics Market Analysis

Mexico Allergy Therapeutics Market was valued at $348 Mn in 2022 and is estimated to reach $582 Mn in 2030, exhibiting a CAGR of 6.65% during the forecast period. The market for allergy treatment medications is expanding as a result of the rising incidence of allergic illnesses and associated health problems. The top leading pharmaceutical companies operating in the market are GlaxoSmithKline, Sanofi, Merck & Co., Novartis, Bayer, Johnson & Johnson, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Grupo farmacéutico Sanfer and Genomma Laboratorios.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Alcohol Addiction Therapeutics Market Analysis

The Mexico Alcohol Addiction Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $18 Mn by 2030, exhibiting a CAGR of 6.55% during the forecast period. The market is fueled by drivers such as increasing prevalence, an increase in the efforts taken by the government to battle addiction, and the adoption of newer advanced technologies by the general population. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Mexico are Elli Lily, Roche, AbbVie, TEVA, Otsuka Pharmaceuticals, GlaxoSmithKline, Johnson & Jhonson, Viatris, Grupo Ferrer and Genomma, among various others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Cardiovascular Drugs Market Analysis

Mexico Cardiovascular Drug Market is at around $2.1 Bn in 2022 and is projected to reach $2.9 Bn in 2030, exhibiting a CAGR of 4.05% during the forecast period. Increased prevalence of disease, greater awareness, and strategic partnerships between pharmaceutical companies and healthcare providers are driving the market. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis

The Mexico Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $50 Mn in 2022, and is predicted to grow at (CAGR) of 8.05% from 2023 to 2030, to US $92 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, rising demand for therapeutics, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Liomont, Novartis, Sanofi, Pfizer Inc, among other players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis

The Mexico Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $17 Mn in 2022, and is predicted to grow at a CAGR of 6.05% from 2023 to 2030, to US $26 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, government initiatives, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Roche, Biogen, AstraZeneca, Janssen among others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Age-Related Macular Degeneration Therapeutics Market Analysis

The Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $162 Mn in 2022 and is predicted to grow at (CAGR) of 9.15% from 2023 to 2030, to US $326 Mn by 2030. The key drivers of this industry include the surge in the prevalence of age-related macular degeneration, technological advancements, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Addiction Therapeutics Market Analysis

Mexico addiction therapeutics market was valued at $152 Mn in 2022 and is estimated to reach $263 Mn in 2030, exhibiting a CAGR of 7.15% during the forecast period. The development of the addiction treatment sector has been fuelled by increased public awareness brought about by anti-drug campaigns and encouraging government initiatives. Major players in the market, including Pfizer, Johnson & Johnson, Novartis, Bristol Myers Squibb, Merck, GlaxoSmithKline, Sanofi, AbbVie, Eli Lilly and Company, and Boehringer Ingelheim, are driving innovations in this field

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Adult Malignant Glioma Therapeutics Market Analysis

The Mexico Adult Glioma Therapeutics Market is valued at around $33 Mn in 2022 and is projected to reach $66 Mn by 2030, exhibiting a CAGR of 9.15% during the forecast period. The market is expanding because of advances in current treatment technologies, rising glioma prevalence, particularly among the elderly, and government measures to expand healthcare coverage. Key players in the Mexico Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Novartis, Pfizer, AbbVie, Bausch Health, Oncoclínica, SteinCares etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Retail Pharmacy Market Analysis

This report presents a strategic analysis of the Mexico Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Retail Pharmacy Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Radiotherapy Market Analysis

By 2030, it is anticipated that the Mexico Radiotherapy Market will reach a value of $xx Mn from $104 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Mexico is dominated by a few domestic players such as Tecnologia en Radioterapia, Medical Plus, and Grupo Gamma. The radiotherapy market in Mexico is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Mexico Radiotherapy is increasing on account of the rise in cancer cases in the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Mexico Physiotherapy Market Analysis

This report presents a strategic analysis of the Mexico Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Physiotherapy Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Pharmaceutical Market Analysis

This report presents a strategic analysis of the Mexico Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Pharmaceutical Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Oncology Therapeutics Market Analysis

By 2030, it is anticipated that the Mexico Oncology Therapeutics Market will reach a value of $5.3 Bn from $2.7 Bn in 2022, growing at a CAGR of 8.65% during 2022-30. The Oncology Therapeutics Market in Mexico is dominated by a few domestic pharmaceutical companies such as Laboratorios Pisa, Grupo Biotoscana, and Liomont. The Oncology Therapeutics Market in Mexico is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Mexico Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Insulin Market Analysis

This report presents a strategic analysis of the Mexico Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Insulin Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Mexico In Vitro Fertilisation (IVF) Service Market Analysis

This report presents a strategic analysis of the Mexico In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Mexico Healthcare Claims Management Market Analysis

This report presents a strategic analysis of the Mexico Healthcare Claims Management Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Healthcare Claims Management Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Mexico ENT Devices Market Analysis

Mexico's ENT Devices Market is projected to grow from $350 Mn in 2022 to $550 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Mexico ENT devices market include ACI Medical, Gamma Medical Instruments, and LAB-MED.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Mexico ECG Equipments Market Analysis

Mexico's ECG Equipment Market is expected to witness growth from $134 Mn in 2022 to $239 Mn in 2030 with a CAGR of 7.55% for the forecasted year 2022-2030. A growing number of people in Mexico are reaching the age of 65 to retire as the country's population increases. To monitor and treat aging-related health issues like heart disease, this demographic trend is boosting demand for healthcare services and diagnostic instruments, particularly ECG equipment. The market is segmented by product type and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Dialysis Market Analysis

This report presents a strategic analysis of the Mexico Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Dialysis Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Diabetes Therapeutics Market Analysis

Mexico's diabetes therapeutics market is expected to witness growth from $2.15 Bn in 2022 to $4.61 Bn in 2030 with a CAGR of 9.95% for the forecasted year 2022-30. Increasing urbanization in Mexico along with unhealthy lifestyle choices are leading to the rising prevalence of diabetes which can be considered the main market driver. The Mexico diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Farmaceutica Maypo, Fifarma, and AstraZeneca are the major players in the Mexico diabetes therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Mexico Dermatology Drugs Market Analysis

This report presents a strategic analysis of the Mexico Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Mexico Dermatology Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Mexico Coronary Stents Market Analysis

Mexico's Coronary Stents Market is expected to witness growth from $170 Mn in 2022 to $250 Mn in 2030 with a CAGR of 5.00% for the forecasted year 2022-30. In Mexico, where the rate and frequency of heart failure are extremely high, it is a significant public health concern. This expands the market for coronary stents and other CAD treatments. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

subscribe to our newsletter
up